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ABSTRACT 
 
Post-traumatic stress disorder (PTSD) and pain often co-occur in the 
same subjects. Chronic pain is a common symptom in subjects with PTSD and 
PTSD is a risk factor for chronic pain and the related disability. PTSD is also 
highly prevalent in subjects with substance abuse disorders. While a number of 
studies have examined interactions between PTSD and chronic pain in general 
populations, these studies have generally used self-reported pain instead of 
experimental pain testing methods. To date, little is known regarding the 
influence of PTSD on pain experience in subjects on opioid maintenance therapy 
for the treatment of opioid addiction. We tested the hypothesis that PTSD is 
associated with altered pain experience in subjects on opioid maintenance 
therapy. Specifically, we examined whether subjects with PTSD would 1) have 
altered sensitivity (pain tolerance and temporal pain summation) to experimental 
pain testing and 2) self-report higher pain severity and pain interference as 
compared to controls.  Forty-one eligible subjects were assessed in the study. All 
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subjects were screened for PTSD using the PTSD Checklist Civilian Version 
(PCL-C). A PCL-C score ≥ 44 was considered as a positive PTSD diagnosis. The 
experimental pain testing and self-assessment of pain experience were 
compared between subjects with and without PTSD. Multivariate analysis was 
used to assess the relation between PTSD and the pain responses adjusting the 
covariates. Our results showed that the presence of PTSD did not alter the 
response to experimental pain testing but significantly increased the degree of 
pain interference as revealed by the subjects’ self-assessment of pain 
experience. These divergent results suggest that in subjects with PTSD there is a 
disconnection between self-reported pain experience and response to 
experimental pain testing with an objective stimulus. The findings discussed in 
this thesis are limited by small sample size. Further study with a larger sample 
size and broader array of pain tests is suggested. 
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INTRODUCTION 
 
Post-traumatic Stress Disorder (PTSD) often coexists with chronic pain 
and is highly prevalent in subjects with substance abuse disorders. 
Understanding the association between PTSD and chronic pain among subjects 
with substance abuse disorders could facilitate better treatment options. Pain is a 
complex subjective experience with sensory-discriminative, cognitive, and 
emotional/affective dimensions. While pain severity is closely related to the 
intensity of noxious stimulation, commonly referred to as the sensory-
discriminative dimension of pain, actual pain experience can be heavily 
influenced by both cognitive and affective factors as well. A number of affective 
factors such as depression and anxiety have been shown to influence clinical 
pain.  As described in the following sections, there is a growing body of research 
showing that pain and the symptoms of PTSD are interrelated in the clinical 
setting. However, little is known regarding the relationship between PTSD and 
pain experience in subjects on opioid maintenance (replacement) therapy for the 
treatment of opioid addiction. Therefore, the primary objective of this research 
project was to assess the influence of PTSD on pain experience in subjects on 
opioid maintenance therapy using both experimental pain testing and subject’s 
self-reporting of pain experience.     
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Historic perspective of PTSD 
PTSD is an anxiety disorder with a large variability in both the range and 
severity of its symptoms. PTSD can occur following traumatic experiences as 
opposed to everyday stressors of lesser magnitude. Examples of traumatic 
experiences include combat exposure, criminal victimization, natural disaster, 
sexual assault, and motor vehicle accident. One of the earliest known instances 
of PTSD was the diagnosis of “railway spine” in 1866 to railroad accident victims 
who experienced symptoms seemingly unrelated to their physical injuries. 
Although it was initially thought that the symptoms of railway spine were 
erroneously attributed to the central nervous system (CNS) damage caused by 
the impact of crash, the symptoms were later attributed to PTSD (Bynum, 2001). 
Historically, psychological symptoms of traumatic exposure in soldiers have been 
well recognized. Following World Wars I and II, returning veterans suffered from 
conditions such as “shell shock”, “war neurosis”, and “combat fatigue”, which all 
describe symptoms similar to those found in PTSD. Through the combined 
efforts of advocates for rape survivors, Vietnam War veterans, and scholars 
studying World War II veterans and concentration camp survivors, the formal 
diagnosis for PTSD was developed (Keane et al., 2006). 
 
Diagnostic criteria of PTSD 
It was not until 1980 that PTSD was first acknowledged as a formal 
diagnostic entity in the 3rd edition of the American Psychiatric Association’s 
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Diagnostic and Statistical Manual (DSM-III) (Orr and Roth, 2000). With advances 
in research, the diagnostic criteria for PTSD have undergone several revisions 
with the latest version, DSM-IV, released in 2000 (American Psychiatric 
Association, 2000). 
 In the latest Diagnostic and Statistical Manual, the criteria for 
experiencing a traumatic event have been changed to require that a person 
“experienced, witnessed, or was confronted with an event or events that involved 
actual or threatened death or serious injury, or a threat to the physical integrity of 
self or others”. Moreover, the person’s response must involve “intense fear, 
helplessness or horror.” Thus, in addition to exposure to a traumatic event, the 
diagnosis for PTSD requires the following five conditions. (1) A person must 
persistently re-experience his/her traumatic event in the form of intrusive 
recollections, recurring dreams, feeling as if the traumatic event were re-
occurring or must exhibit intense psychological distress and physiological 
reactivity when exposed to external cues that resemble the traumatic event. (2) 
PTSD may cause a person to persistently avoid thoughts, feelings, or activities 
associated with the traumatic event or feel detached from others and unable to 
form connections. (3) The person suffering from PTSD will experience hyper-
arousal symptoms such as difficulty falling asleep, irritability, difficulty 
concentrating, hyper-vigilance, and exaggerated startle response. (4) The 
duration of such symptoms must be at least one month. (5) Lastly, the 
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disturbance caused by these symptoms must cause significant distress or 
functional impairment. 
PTSD is classified as acute if the symptoms last between one and three 
months, while symptoms lasting longer than three months are classified as 
chronic. Delayed onset of PTSD can occur if the symptoms begin to manifest 
more than 6 months after the experience of the traumatic event (American 
Psychiatric Association, 2000). 
One of the main symptoms of PTSD is the repeated recollection of the 
traumatic experience, with elements of both physiological distress and 
psychophysiological reactivation. These traumatic memories mediate the link 
between the traumatic experience itself and the hyperarousal and avoidance 
symptoms experienced in PTSD (Mcfarlane, 1992). The repeated activation of 
the traumatic memory also repeatedly activates the acute stress response, along 
with a progressive increase in future reactivity (Mcfarlane et al., 2002). It is 
possible that in PTSD there is a failure to retain and shut off the conditioned fear 
response (Milad et al., 2008). 
 
Prevalence of PTSD due to traumatic events 
Initially, PTSD was thought to be a relatively rare condition with an 
incidence rate of less than 1% in the general population according to the National 
Institute of Mental Health (NIMH) Diagnostic Interview Schedule (DIS) (Helzer et 
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al., 1987). However, the study was controversial due to its small sample size and 
the accuracy of the PTSD diagnosis (Keane et al., 1998).  
Considered to be perhaps the most comprehensive general population 
study, the National Comorbidity Survey (NCS) included a representative sample 
of 5,877 English speaking individuals, 15-54 years of age, living in the contiguous 
United States. According to the NCS, PTSD is a relatively common disease and 
is the 5th most common psychiatric condition in the United States behind only 
major depression, attention-deficit/hyperactivity disorder, specific phobia, and 
social phobia. The lifetime prevalence rate was 7.8%; however, women (10.4%) 
had more than double the prevalence rate of men (5.0%) and 60% of men and 
51% of women had been exposed to one or more traumatic events (Kessler et al., 
1995). Of note is that the original NCS was published in 1995 using what would 
now be considered outdated diagnostic criteria for PTSD. The more recent 
National Comorbidity Survey Replication (NCS-R), a representative sample of 
9,282 English speaking subjects in the contiguous United States, was conducted 
between 2001 and 2003 using the most recent DSM-IV criteria for PTSD. The 
NCS-R estimated that the prevalence rate of PTSD is 6.8% while the projected 
lifetime (up to 75 years of age) risk of developing PTSD was 8.7% (Kessler et al., 
2005). 
The prevalence rate of PTSD in several smaller, more focused studies has 
fallen in line with the results from NCS and NCS-R. For example, in a sample of 
1,007 young adults in the Detroit, Michigan area, the lifetime prevalence of 
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exposure to traumatic events was 39.1% and the overall prevalence of PTSD 
was 9.2%, 11.3% for women and 5.6% for men. The rate of developing PTSD 
from exposure to traumatic events, ranging from 11.6% to 24.0%, did not vary 
significantly by different types of events with the exception of women who 
reported rape (80%) (Breslau et al., 1991). According to a sample of 1,087 
subjects of 18-80 years old in the Netherlands, the lifetime prevalence of 
experiencing a traumatic event was 80.7% while the prevalence of PTSD was 
7.4% (De Vries, 2009). Apparently, although exposure to traumatic events that 
can cause PTSD is a fairly common occurrence, the development of PTSD from 
such exposure remains relatively rare in comparison.  
 
Risk factors: PTSD among high risk populations 
As aforementioned, the majority of people do experience traumatic events 
in their lifetimes, but most do not develop PTSD. However, certain risk factors 
can make individuals more likely to develop PTSD than others. Risk factors 
generally fall into three categories: 1) pre-existing personal and lifestyle factors, 2) 
factors related to the traumatic event itself, and 3) events that occur after the 
traumatic event has already taken place.  
Personal factors associated with anxiety, such as prior trauma, prior life 
adversity, early separation from parents, neuroticism, extraversion, depression, 
antisocial behavior, pre-exiting anxiety, and family history of anxiety or other 
psychiatric problems, can predispose subjects to developing PTSD following 
  7 
traumatic event exposure (Breslau et al., 1991). Lifestyle factors such as low 
education, gender, younger age, marital status, extraversion, and early conduct 
problems, and substance abuse all predispose individuals toward experiencing 
more traumatic events (Breslau et al., 1991; Dohrenwend et al., 2008).  
The nature of the traumatic experience itself can predict the risk for 
development and severity of PTSD. PTSD exhibits a strong “dose-response” 
relationship.  For example, PTSD incidence increased with increasing combat 
exposure (Dohrenwend et al., 2006). Among Vietnam War veterans, Black (33%) 
and Hispanic (32.9%) veterans were more likely to suffer from war-related PTSD 
than white veterans (18.7%) due to a greater exposure (Dohrenwend et al., 
2008). The risk of PTSD was also greater in United Kingdom military units that 
had longer periods of deployment and less time to recuperate between 
deployments (Rona et al., 2007).  
In general, the risk for developing PTSD is significantly greater than the 
general population in certain groups such as military combatants, traumatic 
accident survivors, disaster survivors, women who have suffered rape, refugees, 
and citizens of less economically developed countries.  The incidence of PTSD in 
motor vehicle accident survivors is 43% (Coffey et al., 2006). Among 379 
employees affected by the September 11 terrorist attack, 35% of the survivors 
that were directly exposed to the danger still met DSM-IV PTSD symptom criteria 
(North et al., 2011). Sixteen months after deployment to Iraq, United Kingdom 
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reservists were nearly three (adjusted odds ratio = 2.91) times more likely to 
develop PTSD than controls (Harvey et al., 2012). 
 
Clinical and societal impact of PTSD 
PTSD is a major burden on the public health in the United States and 
many other countries and can have a profound impact on the mental and 
physical health of affected individuals. The psychosocial costs of PTSD present a 
huge burden for affected individuals and society as a whole. According to the 
Global Assessment of Functional Rating Scale, 84.8% of Vietnam veterans with 
war-related PTSD had significant impairment in social roles (Dohrenwend et al., 
2006). Among PTSD sufferers, roughly 80% also had at least one other 
psychiatric disorder such as depression. The odds ratios for agoraphobia, 
obsessive-compulsive disorder, dysthmia, mania, and panic disorder were all 
significantly higher in PTSD sufferers (Breslau et al., 1991; Helzer et al., 1987). 
PTSD is also a strong risk factor for suicide. In addition, PTSD has been shown 
to affect interpersonal relationships between those affected and their loved ones. 
PTSD sufferers are more likely to divorce, have trouble raising their children and 
engaging in intimate partner aggression, be involved in the legal system, 
frequently change jobs, earn less money, and report poorer overall life 
satisfaction (Jordan et al., 1992; Koss et al., 1991; Kulka et al., 1990; Schnurr et 
al., 2004; Walker et al., 2003). 
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The physiological dysregulation caused by PTSD may contribute to a 
range of different physical conditions as well (Kessler et al., 2005). According to 
a cumulative risk model, the severity of stress experienced before or after a 
traumatic event can impact the incidence and severity of the resultant PTSD and 
successive traumatic events progressively increase the occurrence of PTSD (M 
Maes et al., 2001). For example, cumulative exposure to interpersonal violence 
increases the risk of developing PTSD, substance abuse problems, and 
depression (Hedtke et al., 2008). It appears that exposure to trauma disrupts an 
individual’s internal psychophysiology and causes them to then progressively 
become more and more sensitized when repeatedly exposed to triggers. Over 
time, this pattern of increasing sensitivity to environmental triggers can manifest 
as physical symptoms such as hypertension, hyperlipidaemia, obesity, and 
cardiovascular disease (Kibler et al., 2009).  
According to a US study of hypertensive individuals, the September 11, 
2001 attacks, after 2 months, had the effect of increasing systolic blood pressure 
by 1.7 to 3.3 mmHg as compared to the same time in 2000 (Gerin et al., 2005). A 
study of Brazilian police officers found that those officers with PTSD had 
significantly higher levels of cholesterol and triglycerides (Maia et al., 2008). A 
study in Croatia found that those patients with combat-related PTSD had higher 
mean levels of cholesterol and triglycerides but lower levels of HDL-C than a 
group of patients with major depressive disorder (Karlovic et al., 2004). 
Consistent with this clinical observation, patients in the combat-related PTSD 
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group also showed a higher risk for arteriosclerosis than a control group (Kagan 
et al., 1999; Karlovic et al., 2004; Solter et al., 2002).  A study found that police 
officers with severe PTSD had three times the rate of metabolic syndrome found 
in officers with less severe PTSD (Violanti et al., 2006). Metabolic syndrome was 
defined as having three or more of the following components: obesity, elevated 
blood pressure, reduced high density lipoprotein (HDL cholesterol), elevated 
triglycerides, or abnormal glucose.  These findings are supported by another 
study in New Zealand, which showed a similar association between PTSD and 
obesity (odds ratio 2.64) (Scott et al., 2008).  
Collectively, these epidemiological studies have demonstrated a variety of 
detrimental effects of PTSD on both psychosocial and physiological functions.  
PTSD also is a significant contributing factor to a number of diseases.  
 
PTSD and chronic pain 
In addition to a high impact of PTSD on psychosocial and physiological 
functions as described in the above sections, PTSD also has a profound 
influence on clinical pain experience.  Out of all of the psychiatric disorders, 
PTSD has the strongest relationship with medically unexplained pain (Andreski et 
al., 1998). People with PTSD report chronic pain with a strikingly high frequency; 
more than 30% of those who seek outpatient treatment for PTSD in community 
and mental health clinics report chronic pain(Asmundson and Katz, 2009). 
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Pain was once thought to be just a sensory modality in response to 
stimulation of specific high threshold receptors, called nociceptors. This view 
assumed that the relationship between nociceptor activation and pain perception 
would be linear, similar to that seen with other sensory modalities such as smell, 
hearing, and vision. Over years, an increasing number of studies have 
demonstrated that pain is actually a much more complex subjective experience 
influenced by sensory, psychological, and social factors as well as the duration of 
pain experience (Asmundson et al., 2004; Melzack and Katz, 2004). Pain 
normally acts as a useful signal that allows us to adapt to our environment by 
alerting us of potential tissue damage and motivating us to act to avoid tissue 
damage (Wall, 1978). While physical injury or disease is accompanied by pain, 
pain often subsides over time as healing occurs.  In this context, pain serves as a 
useful defensive mechanism.  
However, sometimes pain does not subside and instead impairs normal 
social and occupational functioning while causing significant emotional distress. 
When pain persists for 3 months or more, it is considered as chronic pain (Gureje 
et al., 1998). Chronic pain is one of the most costly and common chronic health 
conditions in North America. In a 12 month period, roughly 10% of the general 
population report experiencing chronic pain conditions (Verhaak et al., 1998). 
The total cost of chronic pain, not including lost productivity from inability to work, 
is estimated to be 100 billion dollars each year in the United States alone 
(Weisberg and Vaillancourt, 1999). In addition, chronic pain affects more 
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Americans, 100 million, than diabetes, cancer, and heart disease combined 
(Institute of Medicine, 2011). 
Not surprisingly, pain has been found to be among the most reported 
symptoms of individuals with PTSD, especially among veterans (Beckham et al., 
1997; Dobie et al., 2004; Engel Jr et al., 2000; Mcfarlane et al., 1994). Veterans 
with PTSD had a 25% incidence of musculoskeletal pain or other pain problems 
(White and Fuastman, 1989). Over the past 25 years, a substantial body of 
research supports the notion that PTSD and pain often co-occur in the same 
subjects. Chronic pain is a common symptom in PTSD subjects. For example, 
chronic pain was found at a much higher rate in combat veterans (66-80%), 
motor vehicle accident survivors (30-50%), and veteran firefighters (45%) with 
PTSD than in the general population. PTSD clearly is a risk factor for chronic 
pain and the related disability (Beckham et al., 1997; Breivik et al., 2006; Chibnall 
and Duckro, 1994; Hickling et al., 1992; Jenewein et al., 2009; Katz et al., 2009; 
Mcfarlane et al., 1994; Shipherd et al., 2007). Increasing PTSD symptoms have 
also been shown to be related to increasing overall pain and pain disability 
(Beckham et al., 1997; Geisser et al., 1996).  Therefore, it would be of 
considerable interest to examine the relationship between PTSD and chronic 
pain in various patient populations. 
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Rationale and objectives of the current study 
While a number of studies have examined the relationship between PTSD 
and chronic pain in general populations, as briefly summarized above, little is 
known regarding the influence of PTSD on pain experience in subjects on opioid 
maintenance therapy for the treatment of opioid addiction. In addition to being 
closely associated with pain, PTSD is also highly prevalent in subjects with 
substance abuse disorders (Brady et al., 2004). In a study of 10,641 participants 
in the Australian National Survey of Mental Health and Well-Being, 33.2% of 
subjects with opioid use disorders also had PTSD. This was the highest rate of 
PTSD amongst all types of substance users studied to date (Mills et al., 2006). In 
another study of 271 patients from VA (Veterans Administration) clinics in 
Philadelphia, Sepuldeva, and the University of Alabama at Birmingham, PTSD 
was diagnosed in 31.4% of opioid addicts (Milby et al., 1996). In contrast, the 
lifetime incidence of PTSD in the general population, as previously reported, is 
much lower at 7.8% (Kessler et al., 2005).  
Despite the well documented evidence that PTSD and pain are closely 
associated, pain measurement in PTSD subjects has largely been conducted by 
self-reporting such that each patient subjectively reports his/her intensity of pain 
experience. However, when it comes to the correlation between self-reported 
pain and experimental pain testing, the literature is mixed. Some studies have 
found that changes in experimental pain sensitivity closely parallel changes in 
clinical pain (Poitras et al., 2002; Sorenson et al., 1997). On the other hand, a 
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study by Edwards and Fillingim in 2007, in a group of 505 people who had 
undergone standardized thermal pain testing (a type of quantitative sensory 
testing), found that actual pain threshold obtained using this measure had no 
statistically significant relationship with subjective self-reported pain sensitivity 
(Edwards and Fillingim, 2007). Another study found that self-reported pain 
sensitivity and pain endurance were not significantly correlated with pain ratings 
derived from suprathreshold noxious thermal stimuli (Robinson et al., 2004). 
Collectively, these findings suggests that a combined approach of using both 
quantitative testing and self-reporting is likely to be more informative in assessing 
the impact of PTSD on pain experience than just self-reporting alone.  
Quantitative sensory testing (QST) has been frequently used to identify 
group differences in pain perception (Edwards et al., 2005). Differences in factors 
such as age, gender, and ethnicity have all been found to influence pain 
perception (Fillingim, 2000; Gibson and Helme, 2001; Green et al., 2003).  
However, very few studies have used QST to examine pain perception 
(somatosensory detection thresholds, pain thresholds, and pain response) in 
PTSD patients and the data remain inconclusive.  
In a study performed by Orr et al in 2000, a “highly annoying but not 
painful” electrical stimulus was applied to the 2nd and 3rd finger of the dominant 
hand of 15 subjects with PTSD, including firefighters, veterans, and assault and 
accident survivors, and 18 controls. The subjects in both groups had other 
psychiatric co-morbidities. It was found that the PTSD group had a lower 
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detection threshold for the electrical stimulation, indicating increased sensitivity 
(Orr et al., 2000). Geuze et al performed a study comparing pain sensitivity of 12 
combat veterans with PTSD to that of 12 non-PTSD combat veterans. Heat pain 
stimuli ranging from 40 to 48 degrees celsius were applied to the dorsal hand 
and pain intensity was recorded using a 1-100 numerical rating scale (NRS). It 
was found that the PTSD subjects rated the objective pain stimulus as less 
painful, indicating reduced pain sensitivity (Geuze et al., 2007). Schmahl et al 
evaluated both heat and cold pain thresholds in four different groups including 16 
subjects with PTSD from mixed sources, 20 subjects with bulimia nervosa, 16 
subjects with borderline personality disorder, and 24 healthy controls. Heat and 
cold pain were applied to the dorsal surface of both hands before and after the 
effects of a mental stressor. It was found that there was no significant difference 
in heat or cold pain thresholds either before or after stress (Schmahl et al., 2008). 
Another study by Defrin et al measured sensory detection and pain thresholds in 
32 subjects with PTSD from mixed sources, 29 subjects with other anxiety 
disorders, and 20 healthy controls. Heat pain stimuli were applied to the dorsal 
surface of both hands by a thermode, and mechanical pain stimuli was applied 
using Von Frey filaments. It was found that both sensory detection and pain 
thresholds were significantly higher in the PTSD group compared to both the 
anxiety and controls groups, indicating that PTSD reduced pain sensitivity 
independent of anxiety. Additionaly, although PTSD increased these thresholds 
in subjects with PTSD, suprathreshold pain stimuli in subjects with PTSD was 
  16 
rated as being more intense than in controls (Defrin et al., 2008). Lastly, a study 
by Kraus et al compared sensory detection and pain thresholds in 10 subjects 
with combat related PTSD, 10 combat controls, and 10 non-combat controls. 
Heat stimuli ranging from 40 to 48 degrees Celsius were applied to the dorsal 
surface of both hands. There was no significant difference in sensory detection 
thresholds between the three groups. However, heat pain thresholds were 
significantly higher in the PTSD group than the combat control or non-combat 
control groups, indicating reduced pain sensitivity in the PTSD group (Kraus et al., 
2009).  
The inconsistency in these study results could have resulted, at least 
partially, from differences in test group characteristics (combat-derived PTSD vs. 
random PTSD samples, gender differences, comorbid psychiatric diagnosis) and 
testing protocols. Further research is needed to study the nature of pain 
perception in PTSD. 
 
Specific aims 
In this study, we will test the overall hypothesis that PTSD is associated 
with altered pain experience in subjects on opioid maintenance therapy, a group 
that is particularly vulnerable to PTSD and pain.  To achieve this goal, results 
from both experimental pain testing (cold pressor test and pinprick test) and 
subject’s self-reported pain severity (questionnaires) will be compared between 
two groups of subjects on opioid maintenance therapy: 1) subjects without PTSD 
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(PTSD negative controls) and 2) subjects with PTSD (PTSD group) as 
determined by a cutoff score of 44 on the Post-traumatic Stress Disorder 
Checklist – Civilian Version (PCL-C). PCL-C is a self-reported questionnaire with 
17 questions designed to rapidly screen subjects for PTSD symptoms and a 
standard tool in PTSD research.  The rationale for using this tool will be further 
described in the Methods section. 
Two specific research hypotheses will be tested as described in the 
following: 
Hypothesis 1): Subjects with PTSD (PCL-C score > 44) would have altered 
sensitivity (pain tolerance and temporal summation) to experimental pain testing 
(cold pressor test and pinprick test) as compared to controls (No PTSD). 
    a)  Subjects with PTSD (PCL-C score > 44) will have altered cold pain 
tolerance as determined by a cold pressor test as compared to controls (No 
PTSD). 
    b) Subjects with PTSD (PCL-C score > 44) will have altered pain summation 
as determined by pinprick test as compared to controls (No PTSD). 
Hypothesis 2): Subjects with PTSD would self-report high pain intensity and 
high pain interference as compared to controls (No PTSD). 
    a) Subjects with PTSD (PCL-C score > 44) will have a high pain severity score 
assessed by Brief Pain Inventory as compared to controls (No PTSD). 
    b) Subjects with PTSD (PCL-C score > 44) will have a high pain interference 
score as assessed by Brief Pain Inventory as compared to controls (No PTSD). 
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METHODS 
 
 Approval for this study as well as the parent study was obtained from the 
Institutional Review Board (IRB) at Boston University. The data presented in this 
thesis were part of the project for a more comprehensive parent study aimed to 
examine whether HCV (hepatitis C virus) infection would be associated with 
changes in experimental and clinical pain in a population of former opioid addicts 
who are currently on opioid maintenance therapy. 
 
Subject recruitment, screening, and study protocol 
This is a cross-sectional study using preliminary experimental data on 41 
subjects; however, the study is still ongoing with the plan to gather data for 120 
subjects. The current data are a subset of this larger study that may take another 
12 months to complete. Therefore, the data reported in this thesis is preliminary 
but will be included in an intended publication at the completion of subject 
recruitment. Accordingly, we will only report on those subjects (n=41) who have 
completed the study in this thesis.  
Study Subjects and Recruitment Methods: Subjects (n=41) were recruited 
from BMC’s office-based opioid treatment (OBOT) program, Boston Public 
Health Commission (BPHC) Opioid Treatment Program, Respect Registry, FAST 
PATH Cohort, and Boston ARCH Cohort via fliers posted in waiting areas and 
examination rooms of the OBOT program clinic and methadone clinics. Boston 
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ARCH research assistants distributed fliers to potential participants who were 
interested in other clinical studies. OBOT and methadone clinic providers, Fast 
PATH study coordinators, and Boston ARCH research assistants were instructed 
to make patients aware of this study and patients who expressed interest were 
either given a number to call or gave their permission for the study coordinator to 
directly contact them. Consent was obtained for permission to access patients’ 
medical records in order to obtain or verify medical information for screening, and 
for participation in the study if found to be eligible. Potential subjects were 
educated about the study process including goals, significance, and potential 
harms and benefits.  
Inclusion Criteria: In order to be eligible for the study, subjects need to   (1) 
be English speaking and between the ages of 18 and 65 years, (2) have 
previously tested positive for HCV and HIV (this is not required for this study, but 
is required for the parent study), and (3) be on methadone or buprenorphine 
maintenance for the treatment of opioid abuse or dependence for at least 30 
days with a stable dose for two consecutive weeks.   
Exclusion Criteria: Subjects were excluded from the study for the following 
reasons. (1) Pregnant women were excluded by rapid urine pregnancy testing 
because pregnancy may be associated with altered pain sensitivity. (2) Subjects 
were also excluded if they had motor, sensory deficits such as weakness and 
numbness or circulatory impairments in the upper extremities because of the 
confounding effect on experimental pain testing. (3) Major psychiatric illness 
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(psychosis) and acute alcohol intoxication were other exclusion criterion because 
of the potential to interfere with subjects’ ability to safely carry out the study 
protocol and give informed consent. (4) Subjects were excluded if they had 
successful HCV treatment for reasons related to the parent study hypothesis, 
and if they were currently taking opioid pain medications not included in opioid 
maintenance therapy because these factors could alter pain sensitivity. (5) Lastly, 
subjects were also excluded for major bleeding diathesis for concern of risks 
related to drawing blood as required in the study protocol. 
Study Protocol:
The two experimental pain testing protocols performed in this study are 
described below. Given the nature of experimental pain testing, subjects were 
asked to refrain from taking over-the-counter pain medications on the day of pain 
testing. However, subjects were allowed to take their usual dose of 
buprenorphine or methadone (opioid maintenance therapy) on the day of pain 
 Eligible subjects were required to complete two study 
visits: a screening visit and a second study visit where experimental pain testing 
was performed and other outcome variables were collected by survey 
questionnaires. Both visits occurred at the BMC GCRU, usually on the same day. 
A study ID number was assigned to all subjects who met basic eligibility and only 
this study ID number, not subject names, was used as an identifier on study 
forms. 
 
Outcome variables 
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testing as well as their usual prescribed medications in order to avoid 
confounding factors such as opioid withdrawal. All sessions of pain testing were 
performed in the morning to ensure that the effects of morning opioid 
maintenance doses on pain responses were constant.  
Cold Pressor Test (CPT): In this study, pain tolerance was defined as the 
latency between the onset of inserting one hand in the cold water device and the 
time point when the subject removed their hand from the water due to the pain 
becoming unbearable. Cold pressor test examines a subject’s tolerability to a 
pre-set noxious stimulation (cold water). This test was conducted using Neslab 
RTE-17 device manufactured by ThermoScientific. The apparatus was filled with 
cold water, continuously cooled to maintain a temperature of 0-2 degrees Celsius. 
Subjects were instructed to place their dominant arm in the cold water bath until 
the water completely covered the hand to above the wrist. Subjects were 
instructed in keep their hands in the cold water device until they could no longer 
tolerate keeping their hands in there. The entire elapsed time (latency) from the 
onset of hand immersion to the point when they could no longer tolerate was 
recorded using a stopwatch, which was used to determine cold pain tolerance. 
To prevent potential injury, subjects were instructed to remove their hands from 
the cold water bath even if they felt no pain at a cutoff time of 5 minutes. 
Immediately after withdrawing their hands, subjects were asked to mark their 
maximum pain intensity on a visual analog scale (VAS) from 0-100 with 0 being 
“no pain” and 100 being “the worst pain one can imagine.” 
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Temporal Pain Summation: Temporal summation of pain is a 
psychophysical correlate of the well-known electrophysiological phenomenon of 
“windup”.  Exacerbated temporal summation suggests a state of enhanced 
central sensitization of nociceptive processing (Price et al., 1994).  To perform 
this test, seven weighted pinprick stimulators purchased and approved by 
BioEngineering were first used to determine pain threshold to mechanical 
stimulation in each subject. Each pinprick stimulator had a flat contact area of 0.2 
mm diameter and exerted a force between 8 and 512 mN. Each of these pinprick 
stimulators was applied to the dorsum of the non-dominant hand in an ascending 
order of force, with a pattern of 2 seconds on followed by 2 seconds off, until a 
perception of (painful) sharpness was felt by the subject. Pinprick stimulators 
were applied twice in ascending order to determine the lowest force pinprick 
stimulator necessary to elicit the perception of sharpness (i.e., pain threshold). 
This stimulator was then used to test for temporal summation by comparing the 
perceived intensity of a single pinprick stimulus to the intensity of a series of 10 
repeated pinprick stimuli of the same stimulator applied at a rate of once per sec 
over 10 seconds within an area of 1 cm2. A subject was asked to rate pain of the 
first stimulus and the pain of the 10th stimulus on a numerical rating scale of 0-
100. There were 2 trials performed.  The raw data from the test were used to 
calculate a pain summation ratio.  The summation ratio was calculated as the 
ratio of the mean pain rating derived from the series of 10 stimuli divided by the 
mean pain rating of the single stimulus. Thus, a higher summation ratio 
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corresponds to higher pain intensity experienced at the 10th stimulus compared 
to the first stimulus, and is considered to be indicative of the phenomenon of 
“wind-up” or temporal summation in these subjects.  
Brief Pain Inventory: The Brief Pain Inventory (BPI) is a 15 item 
questionnaire used to measure both pain intensity and pain interference (the 
impact of pain on a person’s daily functioning). BPI has been shown to be both a 
reliable and valid measure of pain intensity and pain interference (Cleeland and 
Ryan, 1994). Pain severity was assessed by a single question on BPI asking the 
subject to rate “your pain at its average in the past week” on a scale of 0-10 with 
0 and 10 corresponding to “no pain” and “pain as bad as you can imagine”, 
respectively. Pain interference refers to the influence of chronic pain on a variety 
of functions including general activity, mood, walking ability, normal work, 
relationship with other people, sleep, and enjoyment of life. Pain interference was 
measured by taking the average score of seven questions each on a scale of 0-
10 with 0 being “does not interfere” and 10 being “interferes completely”, asking 
how pain has interfered with general activity, mood, walking ability, normal work 
(both work outside the home and housework), relations with other people, sleep 
and enjoyment of life. 
 
Predictor variables 
Demographic and Clinical Information: To obtain information on pain and 
pain-related comorbidities, a study questionnaire was used to gather 
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demographic information on age, sex, race, current and prior drug use, years on 
OAT (opioid agonist treatment), disability status, medications (e.g., gabapentin), 
and other relevant items. 
Post-Traumatic Stress Disorder Checklist-Civilian: PTSD was diagnosed 
in study subjects using the Post-Traumatic Stress Disorder Checklist-Civilian 
(PCL-C). While PTSD is usually diagnosed by a clinician who administers 
structured interviews using the Clinician-Administered PTSD Scale for DSM-IV 
interview (CAPS), this method is time-consuming and the evaluation is often 
inconsistent between different clinicians. The PCL-C is a screening tool 
developed to diagnose PTSD in the civilian population with less time than 
structured interview and without the need for special training. Subjects answered 
17 questions by rating how severely they experienced various PTSD symptoms 
on a 1-5 scale with 1 being “not at all” and 5 being “extremely”. The summed 
score of all 17 questions, which was between 17 and 85, was used to assess 
PTSD. In previous studies of patients who had suffered sexual assault or motor 
vehicle crash (MVC), a cutoff score of 44 on PCL-C was able to diagnose PTSD 
with a sensitivity of 94% and a specificity of 86%.  CAPS was used as a 
reference diagnosis of PTSD against which the PCL-C diagnosis was compared. 
PCL-C had a very close (0.929) correlation with CAPS, showing that PCL-C is a 
reliable tool for diagnosing PTSD. Therefore, in this study, a cutoff score of 44 or 
greater was used as a positive PTSD diagnosis. Using this process, subjects 
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were sorted into two groups: a PTSD positive group and a PTSD negative group 
(Conybeare et al., 2012). 
Patient Health Questionnaire-9: The Patient Health Questionnaire-9 
(PHQ-9) is a 9-item measure of depression directly based on the DSM-IV criteria 
for major depressive disorder. It has a sensitivity and specificity comparable with 
that of other, longer depression measures. Each question on the survey 
corresponds to one of the nine DSM-IV criteria for depression. Subjects 
answered each question with a rating based on how often they have experienced 
that symptom, ranging from a scale of 0-3 with 0 being “not at all” and 3 being 
“nearly every day”. The summed score of nine criteria can range from 0 to 27 
with a higher score indicating more severe depression. PHQ-9 has been shown 
to be a valid and reliable measure of the severity of depression in two studies 
with a combined 6,000 patients (Kroenke and Spitzer, 2002). 
State Trait Anxiety Inventory: The State Trait Anxiety Inventory (STAI) is a 
self-reporting questionnaire that contains a total of 40 questions consisting of two 
sections of 20 questions each, designed to measure both state and trait anxiety 
(Spielberger et al., 1983). For this study, only the 20 question survey measuring 
state anxiety was used. Each question was rated on a 1-4 point scale with higher 
numbers being indicative of greater anxiety, such that 1 and 4 corresponds to 
“not at all” and “very much so”, respectively.  The summed score of all 20 
questions was used as a generalized measure of anxiety ranging from 20-80. 
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The STAI has been shown to be a consistent and valid measure of anxiety with 
internal consistency coefficients ranging from 0.86 to 0.95 (Spielberger, 1989). 
 
Statistical analyses 
Differences in age, gender, race, disability status, PHQ9, State Trait 
Anxiety Inventory (STAI) Score, years on opioid agonist therapy (OAT), and use 
of gabapentin between PTSD positive and PTSD negative groups were assessed 
using t-tests for continuous variables and chi-square tests for categorical 
variables.   
Unadjusted Analyses:  For temporal pain summation between two groups, 
the summation ratio was determined as the ratio of the average final pain rating 
from a series of 10 stimuli delivered during a 10 second period over the pain 
rating in response to a single stimulus. For pain tolerance in cold pressor test 
between groups, the time to withdrawal of the subject’s hand from the cold water 
device was measured. The data for both cold pressor test and temporal 
summation results were natural log transformed in order to address non-
normality/skewness in the data.  Pain interference and severity were based on 
scores (0-10) from the BPI.  To compare statistical differences between subjects 
with and without PTSD, box-plots were compared, and Students t-tests for 
unequal variance were performed.  
Multivariate Analyses:  Multivariate linear regression analysis was used to 
assess the effect of PTSD on pain responses adjusting the influence of multiple 
  27 
clinical factors. Spearman’s correlation matrix was used to assess, for pairs of 
variables for co-linearity. For any two variables with correlation > 0.80, only one 
variable would be included in the multivariate analysis. Given the small sample 
size, there was concern for including too many variables for adjustment; 
therefore, we used a backwards selection strategy to achieve a parsimonious 
model. A stepwise backward selection procedure was used for covariates. 
Starting from a fully adjusted model with all covariates (Age, gender, race, 
disability status, PHQ9 score, STAI score, years on OAT, and gabapentin use), 
we removed covariates in a stepwise fashion starting with covariates with the 
highest p-value for association. Covariates were retained in the adjusted models 
if they had either a p<0.2 for the outcome, or if their inclusion in the model 
caused the parameter estimate for PTSD to change by more than 15% 
(Vittinghoff et al., 2005). All statistical analyses were conducted using using Stata 
version 10 (Stata Corporation; College Station, TX). For all statistical tests, the 
significance level was set at p<0.05.   
 
 
RESULTS 
 
Demographic information and clinical comorbidity 
 A total of 41 subjects were recruited into the study following initial 
screening and they completed both questionnaires and experimental pain testing. 
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Of these 41 patients, 20 (49%) subjects scored above the cutoff of 44 or higher 
on PCL-C and were included in the PTSD group. The remaining 21 subjects 
(51%) who scored lower than 44 on PCL-C were included in the No PTSD control 
group.  
Demographic and clinical characteristics on the subjects in both groups 
are listed in Table 1. Specifically, there were no significant differences in age, 
gender, or on disability status. There were significant differences in race between 
the two groups, with the PTSD group having significantly more white subjects 
and fewer minorities (White 80.1% vs. Non-White 57.1%, p=0.05). Subjects in 
both groups were on an opioid maintenance program as described in the 
Methods section. However, there were no differences in the duration of this 
opioid agonist therapy (OAT) and a number of subjects in both groups were on 
gabapentin, a medication used to treat chronic pain conditions such as 
neuropathic pain. 
As expected, there were significant differences in clinical symptoms of 
depression as assessed by PQH-9 and anxiety disorders as assessed by STAI.    
The data showed that subjects in the PTSD group had a higher average score on 
both PQH-9 (14.9±5.9 vs. 6.9±5.1, p<0.0001) and STAI (40.9±13.8 vs. 27.8±7.1, 
p<0.0001) questionnaires (Table 1). 
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Table 1 
Demographic and Clinical Characteristics 
 Total 
(n=41) 
PTSD 
(n=20) 
No PTSD 
(n=21) 
p 
Age, mean ± SD 43.8 ± 9.3 41.0 ± 8.8 46.5 ± 9.1 0.06 
Gender     
       Male 23 (56.1%) 13 (65.0%) 10 (47.6%) 0.26 
       Female 18 (43.9%) 7 (35.0%) 11 (52.4%)  
Race     
       White 29 (70.7%) 17 (85.0%) 12 (57.1%) 0.05 
       Non-White 11 (29.3%) 3 (15.0%) 9 (42.9%)  
On Disability     
       Yes 18 (43.9%) 9 (45.0%) 9 (42.9%) NS 
       No 23 (56.1%) 11 (55.0%) 12 (57.1%)  
PHQ-9 Score (0-27), mean ± SD 10.8 ± 6.8 14.9 ± 5.9 6.9 ± 5.1 <0.0001 
State Trait Anxiety Inventory Score 
(20-80),mean ± SD 
34.2 ± 12.6 40.9 ± 13.8 27.8 ± 7.1 <0.0001 
Years on OAT, mean ± SD 2.2 ± 2.0 2.0 ± 1.8 2.4 ± 2.2 NS 
On Gabapentin     
       Yes 13 (31.7%) 9 (45.0%) 4 (19.1%) 0.07 
       No 28 (68.3%) 11 (55.0%) 17 (80.9%)  
 
 
Unadjusted outcomes 
 The box plots in Figures 1-4 show each outcome variable (natural log of 
time to hand withdrawal, natural log of windup ratio, average pain in the last 
week, and BPI score) by PTSD status. The box plots suggested a difference 
between groups for average pain in the last week (pain severity) and BPI score. 
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Unadjusted results for experimental pain testing 
 Two items of experimental pain testing were carried out in this study: pain 
tolerance by cold pressor test as well as pain summation by mechanical pinprick 
test. The results from each of these two tests are summarized in Table 2. 
 a) Pain Tolerance: The results from t-tests found that there was no 
significant difference in the latency between PTSD-positive and PTSD-negative 
groups, indicating that subjects in both groups have similar tolerance to 
experimental cold pain stimulation. 
 b) Temporal Pain Summation: Again, the results from t-tests found that 
there was no significant difference in the summation ratio between the PTSD-
positive and PTSD-negative groups, indicating that the degree of pain summation 
in response to experimental painful stimulation (pinprick test) was comparable 
between the two groups.  
 
Unadjusted results on self-reported pain severity and pain interference by 
using Brief Pain Inventory 
a) Pain Severity: As listed in Table 2, there was a difference (4.40±2.33 vs. 
3.38±2.54, p=0.09) in mean score of pain severity between the PTSD and No 
PTSD groups, but this difference was not significant at the p=0.05 level. 
b) Pain Interference: Subjects in the PTSD group rated a statistically 
significant higher mean pain interference score (4.54±2.69 vs. 2.75±2.44, p=0.02) 
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than subjects in the No PTSD group, indicating that PTSD subjects experienced 
a higher degree of pain interference than non-PTSD subjects. 
 
Table 2 
Outcome Variables, Unadjusted 
 Total 
(n=41) 
PTSD 
(n=20) 
No PTSD 
(n=21) 
p 
Natural Log of Time to Withdrawal 
(cold pressor test: pain tolerance); 
mean ± SD (in sec) 
3.26 ± 0.71 3.37 ± 0.73 3.15 ± 0.70 0.34 
Natural Log of Summation Ratio 
(pinprick test: pain summation); 
 mean ± SD (force in gram) 
0.86 ± .68 0.72 ± 0.70 1.00 ± 0.65 0.18 
Pain Severity (Brief Pain Inventory: 
1-10); mean ± SD 
3.88 ± 2.46 4.40 ± 2.33 3.38 ± 2.54 0.09 
Pain Interference (Brief Pain 
Inventory: 1-10); mean ± SD 
3.62 ± 2.69 4.54 ± 2.69 2.75 ± 2.44 0.02 
 
 
Multivariate analysis 
 Multivariate modes were adjusted for age, female gender, non-white race, 
disability status, depression, anxiety, and duration of opioid agonist treatment.   
In addition, because gabapentin has been shown to have a significant pain 
desensitizing effect on cold pressor test and is often prescribed for anxiety, we 
adjusted for this in our models of experimental pain outcomes (Compton et al., 
2010). We used Spearman correlation matrix to assess colinearity between the 
potential covariates and found that no predictors were highly collinear. 
The results using multivariate analysis are described in the following 
sections.    
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 a) Pain Tolerance by Cold Pressor Test:  As shown in Table 3, PTSD did 
not have a significant effect on pain tolerance (unadjusted model: β=0.34; 95% 
CI: -0.235, 0.667; p=0.34), as measured by the natural log of hand withdrawal 
time (latency). Female gender and gabapentin use were found to be significant 
predictors of cold pressor test results (female gender: β=-0.753, p<0.001; on 
gabapentin treatment: β=0.323, p=0.21). In the final adjusted model, after 
adjusting for gender and gabapentin treatment, PTSD remained non-significant 
(β=-0.027; 95% CI: -0.452, 0.398; p=0.90). 
b) Temporal Pain Summation by Pinprick Test: As shown in Table 4, no 
significant association was found between PTSD and summation ratio 
(unadjusted model: β=-0.288; 95% CI: -0.713, 0.138; p=0.18). Age and State 
Trait Anxiety Inventory score were identified as significant predictors of temporal 
summation (age: β=-0.753, p<0.001; STAI score: β=0.323, p=0.21). Adjusting for 
these variables did not appreciably change the results: the association between 
PTSD and summation ratio remained statistically non-significant (β=-0.197; 95% 
CI: -0.677, 0.284; p=0.41). 
c) Pain Severity by Brief Pain Inventory: As shown in Table 5, there was 
no statistically significant association between PTSD and pain severity in the 
unadjusted model (unadjusted model: β=1.02; 95% CI: -0.52, 2.56; p=0.19). 
Using our backwards selection strategy, age, female gender, non-white race, and 
state trait anxiety inventory (STAI) score were retained in the final adjusted 
model (age: β=-0.13, p=0.01; female gender: β=-1.29, p=0.10; non-white race: 
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β=1.28, p=0.17; STAI score: β=-0.05, p=0.16). After adjusting for these variables, 
the relationship between PTSD and pain severity was not appreciably changed 
and still did not meet the level of statistical significance (β=1.07; 95% CI: -0.70, 
2.85; p=.23). 
d) Pain Interference by Brief Pain Inventory:
 
 As shown in Table 6, the 
unadjusted analysis suggested that there was a significant difference in pain 
interference between the subjects with and without PTSD (β=1.79; 95% CI: 0.17, 
3.41; p=0.03). Using our backwards selection strategy, disability status was 
retained in the final adjusted model (β=1.67, p=0.04). The final adjusted model 
showed that this relationship remained significant (β=1.75; 95% CI: 0.20, 3.30; 
p=0.03), indicating that PTSD was associated with greater pain interference (i.e. 
pain that interfered with daily living) in these subjects and this relationship is 
independent of the disability status. 
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Table 3: Multivariable Analysis for Pain Tolerance (Cold Pressor Test) 
*Natural Log of Time to Hand Withdrawal 
 Unadjusted Adjusted Final Model 
Predictor β 
(95% CI) 
p β 
(95% CI) 
p 
PTSD (Primary Predictor) 0.216 
(-0.235 – 0.667) 
0.34 -0.027 
(-0.452 – 0.398) 
0.90 
Age - - - - 
Female Gender - - -0.775 
(-1.198 – -3.512) 
<0.01 
Non-White Race - - - - 
On Disability - - - - 
PHQ-9 (Depression) - - - - 
State Trait Anxiety 
Inventory 
- - - - 
Years on OAT - - - - 
On Gabapentin - - 0.417 
(-0.047 – 0.880) 
0.08 
 
Table 4: Multivariable Analysis for Temporal Summation (Pinprick Test) 
*Natural Log of Summation Ratio 
 Unadjusted Adjusted Final Model 
Predictor β 
(95% CI) 
p β 
(95% CI) 
p 
PTSD (Primary Predictor) -0.288 
(-0.713 – 0.138) 
0.18 -0.197 
(-0.677 – 0.284) 
0.41 
Age - - -0.025 
(-0.049 – -0.001) 
0.04 
Female Gender - - - - 
Non-White Race - - - - 
On Disability - - - - 
PHQ-9 (Depression) - - - - 
State Trait Anxiety 
Inventory 
- - -0.018 
(-0.037 – 0.002) 
0.08 
Years on OAT - - - - 
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Table 5: Multivariable Analysis for Pain Severity 
Subject Self-reporting (1-10 scale) 
 Unadjusted Adjusted Final Model 
Predictor β 
(95% CI) 
p β 
(95% CI) 
p 
PTSD (Primary Predictor) 1.02 
(-0.52 – 2.56) 
0.19 1.07 
(-0.70 – 2.85) 
0.23 
Age - - -0.13 
(-0.23 – -0.04) 
0.01 
Female Gender - - -1.29 
(-2.87 – 0.28) 
0.10 
Non-White Race - - 1.28 
(-0.57 – 3.13) 
0.17 
On Disability - - - - 
PHQ-9 (Depression) - - - - 
State Trait Anxiety 
Inventory 
- - -0.05 
(-0.12 – 0.02) 
0.16 
Years on OAT - - - - 
 
Table 6: Multivariable Analysis for Pain Interference 
Subject Self-reporting (1-10 scale) 
 Unadjusted Adjusted Final Model 
Predictor β 
(95% CI) 
p β 
(95% CI) 
p 
PTSD (Primary Predictor) 1.79 
(0.17 – 3.41) 
0.03 1.75 
(0.20 – 3.30) 
0.03 
Age - - - - 
Female Gender - - - - 
Non-White Race - - - - 
On Disability - - 1.67 
(0.11 – 3.23) 
0.04 
PHQ-9 (Depression) - - - - 
State Trait Anxiety 
Inventory 
- - - - 
Years on OAT - - - - 
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DISCUSSION 
 
The present study was conducted to examine the influence of PTSD on 
pain experience in subjects on opioid (methadone or buprenorphine) 
maintenance therapy for the treatment of opioid addiction. Both experimental 
pain testing and subject’s self-reported pain experience were used to test two 
major hypotheses: 1) subjects with PTSD would have either increased or 
decreased sensitivity to experimental pain testing as compared to control 
subjects (No PTSD); and 2) subjects with PTSD would self-report exacerbated 
pain (higher pain severity and pain interference) as compared to control subjects 
(No PTSD). Collectively, the results indicate that the presence of PTSD did not 
exacerbate responses to experimental pain testing as administered by a cold 
pressor test or mechanical pinprick test. The data also indicate that subjects with 
PTSD demonstrated more personal distress as reflected by a significantly higher 
pain interference score, and a trend toward greater pain severity, though not 
quite meeting level of significance possibly related to our sample size limitations. 
These results are independent of factors of age, gender, race (White vs. Non-
White), disability status (yes or no), depression (mean PHQ-9 score), anxiety 
(mean State Trait score) and years on opioid agonist therapy (OAT). 
Hypothesis 1: Experimental pain testing in PTSD populations is an 
underexplored area of research and the current data in the literature remains 
inconclusive. Out of four previous studies that measured pain thresholds in PTSD 
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patients, two studies found an increased pain threshold corresponding to 
reduced pain sensitivity, one found a decreased pain threshold corresponding to 
increased pain sensitivity, and one found no change in pain threshold. Based on 
these previous data, we hypothesized that there would be a significant difference, 
either positive or negative, in the latency of hand withdrawal time in cold pressor 
test (pain tolerance) between the PTSD positive and PTSD negative groups. 
Furthermore, we hypothesized that there would be a significant difference in 
temporal summation of painful response to pinprick stimulation, reflected by a 
summation ratio, between the PTSD positive and PTSD negative groups. Our 
results demonstrate that, as compared to subjects without PTSD, subjects with 
PTSD showed no significant differences in pain sensitivity or pain summation, as 
reflected by withdrawal latency in the cold pressor test and summation ratio in 
the pinprick test, respectively. While the results of this study did not support the 
hypothesis, they are not wholly inconsistent with the previous literature. The 
results from experimental pain testing appear to be largely in agreement with the 
notion found in the study by Schmahl et al. that subjects with PTSD have no 
change in pain sensitivity, and the discordant results from the other three studies 
also seem to indicate that PTSD has no effect on pain sensitivity (Geuze et al., 
2007; Kraus et al., 2009; Orr et al., 2000; Schmahl et al., 2008). 
Hypothesis 2: A large body of research has shown that PTSD and chronic 
pain often co-exist in the same subjects (Asmundson and Katz, 2009).  
Accordingly, we hypothesized that positive PTSD diagnosis would be associated 
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with greater pain interference, and pain severity. The data from this study is 
consistent with the preexisting research in that significantly higher pain 
interference was demonstrated in the PTSD group as compared to the non-
PTSD controls.  Moreover, while not statistically significant, pain severity ratings 
were also higher in the PTSD group relative to the control group. With a larger 
sample size, we expect that these differences would likely have been statistically 
significant.  
Taken together, these findings suggest that in subjects with PTSD there is 
a disconnection between self-reported pain experience and response to 
experimental pain testing with an objective stimulus. 
 
Influence of PTSD on pain experience 
The current data indicate that subjects with PTSD on opioid maintenance 
therapy have a distinct pattern of response to experimental pain testing versus 
self-reporting of pain. The current study did not reach a statistically significant 
difference in pain tolerance by cold pressor test (p=0.90) or pain summation by 
pinprick test (p=0.41) between subjects with and without PTSD. On the other 
hand, since the symptoms of PTSD would have conceivably influenced the 
subjects’ functional status, it is consistent that our results showed a significantly 
increased pain interference score (p=0.03) when the subjects with PTSD self-
assessed their pain experience.  
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The dichotomous response pattern (no change in pain intensity by 
experimental testing but exacerbated pain interference by self-reporting) 
observed in this study is consistent with previous studies that found no 
association between self-reported pain sensitivity and laboratory-derived 
measures of pain (Edwards and Fillingim, 2007; Robinson et al., 2004).  
In addition, we believe that the dichotomous response pattern observed in 
our results is supported by the neuromatrix theory of pain wherein pain is not just 
a sensation caused by injury or inflammation, but a complex multidimensional 
experience with many causes. According to the neuromatrix theory of pain 
(Malzack, 2005), the body-self neuromatrix is the network of neurons that 
consists of loops between the thalamus and cortex and also between the cortex 
and limbic system. The neurosignature is the characteristic pattern of the cyclical 
processing and synthesis of nerve impulses within the body-self neuromatrix. 
The neurosignature is projected to the sentient neural hub of the brain where it is 
converted to a stream of awareness including pain perception (Melzack, 2005). 
Pain perception, one of the outputs of the neurosignature, is thought to be 
influenced by sensory, affective, and cognitive factors. Sensory factors include 
cutaneous, visceral, and musculoskeletal inputs; cognitive factors include 
memories of past experiences, attention, and anxiety; and affective inputs 
include homeostatic and stress mechanisms (Melzack, 2005). Thus, pain is 
influenced by cognitive and affective factors as well as sensory factors. The fact 
that PTSD is associated with so many of these cognitive and affective factors 
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helps explain why patients self-reported more pain, as shown by pain 
interference and pain severity, in this study. On the other hand, in experimental 
pain testing, all subjects experienced a standardized level of noxious stimuli, 
including cold pressor test and mechanical pinprick. 
Although the cellular and molecular mechanism underlying the interaction 
between PTSD and chronic pain remains unclear, two psychosocial models, the 
mutual maintenance model and the shared vulnerability model, have been 
proposed to explain the apparent relationship between PTSD and chronic pain. 
According to the mutual maintenance model, certain physiological, behavioral, 
and affective components of PTSD increase the symptoms of pain, whereas 
cognitive, affective, and behavioral components of pain likewise exacerbate the 
symptoms of PTSD.  Several specific mechanisms have been proposed to 
explain how the mutual maintenance is mediated between PTSD and chronic 
pain: 1) attentional and reasoning biases, 2) anxiety sensitivity, 3) reminders of 
trauma, 4) avoidance, 5) depression and reduced anxiety levels, 6) anxiety and 
pain perception, and 7) cognitive demand from symptoms limiting use of adaptive 
strategies. A patient would be caught in a vicious cycle where the symptoms of 
PTSD and chronic pain reinforce each other to produce self-perpetuating distress 
and functional disability (Sharp and Harvey, 2001). 
On the other hand, the shared vulnerability model posits that individual 
genetic differences can predispose certain people to develop both chronic pain 
and PTSD when exposed to environmental cues. Specifically, this model 
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suggests that the interaction of a psychological vulnerability for feelings of loss of 
control, a lowered physiological threshold for reactions to stressors such as flight 
response, and a traumatic incident or injury all could influence negative 
emotional responses and their consequences.  This model has been used to 
explain the development of PTSD, chronic musculoskeletal pain, and their co-
occurrence.  As such, co-existing PTSD and chronic musculoskeletal pain are 
most likely to be observed in those “vulnerable” people who are exposed to an 
event that is both painful and traumatic, in which reminders of the trauma and 
sensations of pain can serve as triggers for further reactions.  The essence of 
this shared vulnerability model is consistent with the mutual maintenance model 
but further illustrates how predisposing factors can contribute to maintenance of 
PTSD, chronic pain, and their comorbid interactions (Asmundson et al., 2002; 
Asmundson and Taylor, 2006; Otis et al., 2003; Turk, 2002).  
Given the similarities in the response to experimental pain testing and self-
reporting of pain interference between subjects with PTSD as reported in the 
present and previous studies, it is reasonable to suggest that the underlying 
psychosocial mechanism of our findings would be, at least partially, supported by 
the tenets described in both the mutual maintenance model and the shared 
vulnerability model.  
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Study limitations 
Several points (sample size, experimental pain testing modality, and 
subject characteristics) should be considered when evaluating the results of this 
study. The sample size in this study was 41 subjects, while the six previous 
studies using QST methods to measure pain in PTSD populations used between 
16 and 81 patients (Moeller-Bertram et al., 2012). The small sample size limited 
the statistical power of data analysis. Subject recruitment for this study is still 
ongoing and we expect that the study power will be increased when the number 
of subjects (up to 120) proposed for the parent study is finally reached.  
Differences in subject characteristics such as age, gender, race, prior 
medications, and comorbid psychiatric disorders including anxiety and 
depression could all have been implicated as important confounders, but were 
adjusted for in the analysis. Although these significant covariates were adjusted 
for, unmeasured confounding can not be completely ruled out as a contributing 
factor to our results. 
Some of the differences between the QST results of this study and 
previous studies may be attributed to the differences between testing protocols 
and subject characteristics. Some investigators have suggested that 
experimental pain testing methods that can produce deep and prolonged pain 
could more closely resemble clinical pain states than superficial heat application 
(Sessle, 1990). Previous studies used heat stimulation applied to the dorsal 
surface of one or both hands, while this study used cold pressor test. In this 
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regard, cold pressor test requiring hand immersion into a cold water container 
may better simulate clinical pain states by producing more deep and prolonged 
pain than transient heat stimuli (Moeller-Bertram et al., 2012). Subject 
characteristics could also have had an effect on the results of experimental pain 
testing in this study. Like some studies using a mixed group of PTSD subjects, in 
this study we did not categorize subjects by the type of traumatic event that led to 
PTSD, whereas several previous studies recruited only combat-related PTSD 
subjects (Defrin et al., 2008; Geuze et al., 2007; Kraus et al., 2009; Orr et al., 
2000; Schmahl et al., 2008). These differences in subject characteristics could 
have contributed to the inconsistency in results between studies. Therefore, due 
to the nature of the noxious stimuli used and the etiology of PTSD, the results 
from previous QST studies may differ from our results. 
There is a clear need for further studies on PTSD using experimental pain 
testing to compare with the information gathered from a subject’s self-reporting. 
Given the complex relationship between PTSD and pain, future protocols need to 
use more uniform experimental pain testing methods, preferably those that best 
resemble clinical pain states such as cold pressor test. Finally, since the current 
study used a cross-sectional observational design, which focuses on a single 
point analysis of pain experience in these subjects, future investigation may 
consider using a longitudinal study design to examine chronological differences 
in pain experience between subjects with and without PTSD on opioid 
maintenance therapy. 
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Conclusion 
 The relationship between pain and PTSD is a very complex issue. While 
preliminary data from 41 study subjects has been collected for this thesis, an 
important goal of the parent study is to collect data for all 120 subjects. 
Nonetheless, the results after 41 study subjects suggest that there is no 
difference in experimental pain sensitivity in study subjects with and without 
PTSD, but there is more self-reported pain in the same study subjects. This lack 
of correlation between self-reported pain sensitivity and response to experimental 
pain testing implies that there is more to pain perception than just nociceptive 
input. According to the neuromatrix theory of pain, not only sensory, but also 
cognitive and affective factors can all influence pain perception. The association 
between PTSD and chronic pain may be explained by the fact that PTSD 
symptoms are associated with many of the cognitive and affective factors that 
are thought to increase pain perception. Thus, when treating patients with PTSD 
suffering from chronic pain symptoms, it is important for health care providers to 
address PTSD symptoms as part of the treatment for chronic pain. 
 
 
 
 
 
 
  47 
REFERENCES 
  
American Psychiatric Association, 2000. Diagnostic and Statistical Manual for 
Mental Disorders. Text Revision, fourth ed. American Psychiatric 
Association. Washinton (DC). 
 
Andreski P, Chilcoat H, Breslau N, 1998. Post-Traumatic Stress Disorder and 
Somatization Symptoms: a Prospective Study. Psychiatry Research 
79:131-138. 
 
Asmundson GJG, Coons MJ, Taylor S, Katz J, 2002. PTSD and the Experience 
of Pain: Research and Clinical Implications of Shared Vulnerability and 
Mutual Maintenance Models. Canadian Journal of Psychiatry 47:930-937. 
 
Asmundson GJG, Katz J, 2009. Understanding the Co-Occurrence of Anxiety 
Disorders and Chronic Pain: State-Of-The-Art. Depression and Anxiety 
26:888-901. 
 
Asmundson GJG, Taylor S, 2006. PTSD and Chronic Pain: Cognitive-Behavioral 
Perspectives and Practical Implications. In: Causality: Psychological 
Knowledge and Evidence in Court (Young G, Kane AW, Nicholson K, eds). 
New York: Springer; 225-241. 
 
Asmundson GJG, Wright KD, Stein MB, 2004. Pain and PTSD Symptoms in 
Female Veterans. European Journal of Pain 8:345-350. 
 
Beckham JC, Crawford AL, Feldman ME, Kirby AC, Hertzberg MA, Davidson 
JRT, Moore SD, 1997. Chronic Posttraumatic Stress Disorder and Chronic 
Pain in Vietnam Combat Veterans. Journal of Psychosomatic Research 
43:379-389. 
 
Brady KT, Sudie EB, Coffey SF, 2004. Substance Abuse and Posttraumatic 
Stress Disorder. Current Directions in Psychological Science 13:206-2009. 
 
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D, 2006. Survey of 
Chronic Pain in Europe: Prevalence, Impact on Daily Life, and Treatment. 
European Journal of Pain 10:287-333. 
 
Breslau N, Davis GC, Andreski P, Peterson E, 1991. Traumatic Events and 
Posttraumatic Stress Disorder in an Ubran Population of Young Adults. 
Archives of General Psychiatry 48:216-222. 
 
Bynum B, 2001. Discarded Diagnosis. The Lancet 358:339. 
  48 
 
Chibnall JT, Duckro PN, 1994. Post-Traumatic Stress Disorder in Chronic Post-
Traumatic Headache Patients. Headache 34:357-361. 
 
Cleeland CS, Ryan KM, 1994. Pain Assessment: Global Use of the Brief Pain 
Inventory. Annals Academy of Medicine 23:129-138. 
 
Coffey SF, Gudmundsdottir B, Beck JG, Palyo SA, Miller L, 2006. Screening for 
PTSD in Morot Vehicle Accident Survivors Using the PSS-SR and IES. 
Journal of Traumatic Stress 19:119-128. 
 
Compton P, Kehoe P, Sinha K, Torrington MA, Ling W, 2010. Gabapentin 
Improves Cold-Pressor Pain Responses in Methadone-Maintained 
Patients. Drug and Alcohol Dependence 109:213-219. 
 
Conybeare D, Behar E, Solomon A, Newman MG, Borkovec TD, 2012. The 
PTSD Checklist - Civilian Version: Reliability, Validity, and Factor 
Structure in a Nonclinical Sample. Journal of Clinical Psychology 68:699-
713. 
 
De Vries G-J, 2009. The Lifetime Prevalence of Traumatic Events and 
Posttraumatic Stress Disorder in the Netherlands. Journal of Traumatic 
Stress 22:259-267. 
 
Defrin R, Ginzburg K, Solomon Z, Polad E, Bloch M, Govezensky M, Schreiber S, 
2008. Quantitative Testing of Pain Perception in Subjects with PTSD - 
Implications for the Mechanism of the Coexistence Between PTSD and 
Chronic Pain. Pain 138:450-459. 
 
Dobie DJ, Kivlahan DR, Maynard C, Bush KR, Davis TM, Katharine BA, 2004. 
Posttraumatic Stress Disorder in Female Veterans. Archives of Internal 
Medicine 164:394-400. 
 
Dohrenwend BP, Turner JB, Turse NA, Adams BG, Koenen KC, Marshall R, 
2006. The Psychological Risk of Vietnam for US Veterans: A Revisit with 
New Data and Methods. Science 313. 
 
Dohrenwend BP, Turner JB, Turse NA, Lewis-Fernandez R, Yager TJ, 2008. 
War-Related Posttraumatic Stress Disorder in Black, Hispanic, and 
Majority White Vietnam Veterans: The Roles of Exposure and Vulnerability. 
Journal of Traumatic Stress 21:133-141. 
 
  49 
Edwards RR, Fillingim RB, 2007. Self-Reported Pain Sensitivity: Lack of 
Correlation with Pain Threshold and Tolerance. European Journal of Pain 
11:594-598. 
 
Edwards RR, Sarlani E, Wesselmann U, Fillingim RB, 2005. Quantitative 
Assessment of Experimental Pain Perception: Multiple Domains of Clinical 
Relevance. Pain 114:315-319. 
 
Engel Jr CC, Liu X, McCarthy BD, Miller RF, Ursano R, 2000. Reationship of 
Physical Symptoms to Posttraumatic Stress Disorder Among Veterans 
Seeking Care for Gulf War-Related Health Concerns. Psychosomatic 
Medicine 62:739-745. 
 
Fillingim RB, 2000. Sex, Gender and Pain: Women and Men Really are Different. 
Current Review of Pain 4:24-30. 
 
Geisser ME, Roth RS, Bachman JE, Eckert TA, 1996. The Relationship Between 
Symptoms of Post-Traumatic Stress Disorder and Pain, Affective 
Disturbance and Disability Among Patients with Accident and Non-
Accident Related Pain. Pain 66:207-214. 
 
Gerin W, Chaplin W, Schwartz JE, 2005. Sustained Blood Pressure Increase 
After an Acute Stressor: the Effects of the 11 September 2001 Attack on 
the New York City World Trade Center. Journal of Hypertension 23:279-
284. 
 
Geuze E, Vermetten E, Jochims A, Bohus M, Schmahl C, Westenberg H, 2007. 
Neuroimaging of Pain Perception in Dutch Veterans With and Without 
Posttraumatic Stress Disorder: Preliminary Results. Annals New York 
Academy of Sciences 1071:401-404. 
 
Gibson SJ, Helme RD, 2001. Age-Related Differences in Pain Perception and 
Report. Clinics in Geriatric Medicine 17:433. 
 
Green CR, Anderson KO, Baker TA, Campbell LC, Decker S, Fillingim RB, 
Kaloukalani DA, Lasch KE, Myers C, Tait RC, Todd KH, Vallerand AH, 
2003. The Unequal Burden of Pain: Confronting Racial and Ethnic 
Disparities in Pain. Pain Medicine 4:277-294. 
 
Gureje O, Von Korff M, Simon GE, Gater R, 1998. Persistent Pain and Well 
Being: a World Health Organization Study in Primary Care. Journal of the 
American Medical Association 280:147-151. 
 
  50 
Harvey SB, Hatch SL, Jones M, Hull L, Jones N, Greenberg N, Dandeker C, Fear 
NT, Wessely S, 2012. The Long-Term Consequences of Military 
Deployment: A 5-Year Cohort Study of United Kingdom Reservists 
Deployed to Iraq in 2003. American Journal of Epidemiology 176:11177-
11184. 
 
Hedtke KA, Ruggiero KJ, Fitzgerald MM, 2008. A Longitudinal Investigation of 
Interpersonal Violence in Relation to Mental Health and Substance Use. 
Journal of Consulting and Clinical Psychology:633-647. 
 
Helzer JE, Robins LN, McEvoy L, 1987. Post-Traumatic Stress Disorder in the 
General Population. The New England Journal of Medicine 317:1630-
1634. 
 
Hickling EJ, Blanchard EB, Silverman DJ, Schwarz SP, 1992. Motor Vehicle 
Accidents, Headaches and Post-Traumatic Stress Disorder: Assessment 
Findings in a Consecutive Series. Headache 32. 
 
Institute of Medicine, 2011. Relieving Pain in America, A Blueprint for 
Transforming Prevention, Care, Education, and Research. Institute of 
Medicine. Washington (DC). 
 
Jenewein J, Wittmann L, Moergli H, 2009. Mutual Influence of Posttraumatic 
Stress Disorder Symptoms and Chronic Pain Among Injured Accident 
Survivors: A Longitudinal Study. Journal of Traumatic Stress 22:540-548. 
 
Jordan BK, Marmar CR, Fairbank JA, Schlenger WE, Kulka RA, 1992. Problems 
in Families of Male Vietnam Veterans with Posttraumatic Stress Disorder. 
Journal of Consulting and Clinical Psychology 60:916-926. 
 
Kagan BL, Leskin G, Haas B, 1999. Elevated Lipid Levels in Vietnam Veterans 
with Chronic Posttraumatic Stress Disorder. Biological Psychiatry 45:374-
377. 
 
Karlovic D, Buljan D, Martinac M, 2004. Serum Lipid Concentrations in Croatian 
Veterans with Post-Traumatic Stress Disorder, Post-Traumatic Stress 
Disorder Comorbid with Major Depressive Disorder, or Major Depressive 
Disorder. Journal of Korean Medical Science 19:431-436. 
 
Katz J, Asmundson GJG, McRae K, Halket E, 2009. Emotional Numbing and 
Pain Intensity Predict the Development of Pain Disability up to One Year 
After Lateral Thoracotomy. European Journal of Pain 13:870-878. 
 
  51 
Keane TM, Kolb LC, Kaloupek DG, Orr SP, Blanchard EB, Thomas RG, Hsieh 
FY, Lavori PW, 1998. Utility of Psychophysiology Measurement in the 
Diagnosis of Posttraumatic Stress Disorder: Results from a Department of 
Veteran's Affairs Cooperative Study. Journal of Consulting and Clinical 
Psychology 66:914-923. 
 
Keane TM, Marshall AD, Taft CT, 2006. Posttraumatic Stress Disorder: Etiology, 
Epidemiology, and Treatment Outcome. Annual Review of Clinical 
Psychology 2:161-197. 
 
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE, 2005. 
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders 
in the National Comorbidity Survey Replication. Archives of General 
Psychiatry 62:593-602. 
 
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB, 1995. Posttraumatic 
Stress Disorder in the National Comorbidity Survey. Archives of General 
Psychiatry 52:1048-1060. 
 
Kibler JL, Joshi K, Ma M, 2009. Hypertension in Relation to Posttraumatic Stress 
Disorder and Depression in the US National Comorbidity Survey. 
Behavioral Medicine 34:125-132. 
 
Koss MP, Koss PG, Woodruff WJ, 1991. Deleterious Effects of Criminal 
Victimization on Women's Health and Medical Utilization. Archives of 
Internal Medicine 151:342-347. 
 
Kraus A, Geuze E, Schmahl C, Greffrath W, Treede R-D, Bohus M, Vermetten E, 
2009. Differentiation of Pain Ratings in Combat-Related Posttraumatic 
Stress Disorder. Pain 143:179-185. 
 
Kroenke K, Spitzer RL, 2002. The PHQ-9: A New Depression Diagnostic and 
Severity Measure. Psychiatric Annals 32:1-7. 
 
Kulka RA, Schlenger WE, Fairbank JA, Hough RL, Jordan BK, 1990. Trauma 
and the Vietnam War Generation: Report of Findings from the National 
Vietnam Veterans Readjustment Study. New York: Brunner/Mazel. 
 
M Maes, Mylle J, Delmeire L, 2001. Pre- and Post-Disaster Negative Life Events 
in Relation to the Incidence and Severity of Post-Traumatic Stress 
Disorder. Psychiatry Research 105:1-12. 
 
  52 
Maia DB, Marmar CR, Mendlowicz MV, 2008. Abnormal Serum Lipid Profile in 
Brazilian Police Officers with Post-Traumatic Stress Disorder. Journal of 
Affective Disorders 107:259-263. 
 
Mcfarlane AC, 1992. Avoidance and Intrusion in Posttraumatic Stress Disorder. 
Journal of Nervous and Mental Disease 180:439-445. 
 
Mcfarlane AC, Atchison M, Rafalowicz E, Papay P, 1994. Physical Symptoms in 
Post-Traumatic Stress Disorder. Journal of Psychosomatic Research 
38:715-726. 
 
Mcfarlane AC, Yehuda R, Clark CR, 2002. Biologic Models of Traumatic 
Memories and Post-Traumatic Stress Disorder. Psychiatric Clinics of 
North America 25:253-270. 
 
Melzack R, 2005. Evolution of the Neuromatrix Theory of Pain. The Prithvi Raj 
Lecture: Presented at the Third World Congress of World Institute of Pain, 
Barcelona 2004. Pain Practice 5:85-94. 
 
Melzack R, Katz J, 2004. The Gate Control Theory: Reaching for the Brain. In: 
Pain: Psychological Perspectives (Hadjistavropoulos T, Craig KD, 
Mahwah NJ, eds): Lawrence Erlbaum Associates; 13-34. 
 
Milad MR, Orr SP, Lasko NB, 2008. Presence and Acquired Origin of Reduced 
Recall for Fear Extinction in PTSD: Results of a Twin Study. Journal of 
Psychiatric Research 42:515-520. 
 
Milby JB, Sims MK, Khuder S, Schumacher JE, Huggins N, 1996. Psychiatric 
Comorbidity: Prevalence in Methadone Maintenance Treatment. American 
Journal of Drug and Alcohol Abuse 22:95-107. 
 
Mills KL, Teesson M, Ross J, Peters L, 2006. Trauma, PTSD, and Substance 
Use Disorders: Findings From the AustralianNational Survey of Mental 
Health and Well-Being. American Journal of Psychiatry 163:651-658. 
 
Moeller-Bertram T, Keltner J, Strigo IA, 2012. Pain and Post Traumatic Stress 
Disorder - Review of Clinical and Experimental Evidence. 
Neuropharmacology 62:586-597. 
 
North CS, Pollio DE, Smith RP, King RV, Pandya A, Suris AM, Hong BA, Dean 
DJ, Susser E, Pfefferbaum B, 2011. Trauma Exposure and Posttraumatic 
Stress Disorder Among Employees of New York City Companies Affected 
by the September 11, 2001 Attacks on the World Trade Center. Disaster 
Medicine and Public Health Preparedness 5:E1-E9. 
  53 
Orr SP, Metzger LJ, Lasko NB, Peri T, Macklin ML, Pitman RK, 2000. De Novo 
Conditioning in Trauma-Exposed Individuals With and Without 
Posttraumatic Stress Disorder. Journal of Abnormal Psychology 109:290-
298. 
 
Orr SP, Roth WT, 2000. Psychophysiological Assessment: Clinical Applications 
for PTSD. Journal of Affective Disorders 61:225-240. 
 
Otis JD, Keane TM, Kerns RD, 2003. An Examination of the Relationship 
Between Chronic Pain and Post-Traumatic Stress Disorder. Journal of 
Rehabilitation Research & Development 40:397-405. 
 
Poitras P, Riberdy PM, Plourde V, Boivin M, Verrier P, 2002. Evolution of 
Visceral Sensitivity in Patients with Irritable Bowel Syndrome. Digestive 
Diseases and Sciences 47:914-920. 
 
Price DD, Mao J, Frenk H, Mayer DJ, 1994. The N-methyl-D-aspartate Receptor 
Agonist Dextromethorphan Selectively Reduces the Temporal Summation 
of the Second Pain in Man. Pain 59:165-174. 
 
Robinson ME, Wise EA, Gagnon C, Fillingim RB, Price DD, 2004. Influences of 
Gender Role and Anxxiety on Sex Differences in Temporal Summation of 
Pain. Journal of Pain 5:77-82. 
 
Rona RJ, Fear NT, Hull L, 2007. Mental Health Consequences of Overstretch in 
the UK Armed Forces. British Medical Journal 335:603. 
 
Schmahl C, Meinzer M, Zeuch A, Fichter M, Cebulla M, Kleindienst N, Ludascher 
P, Steil R, Bohus M, 2008. Pain Sensitivity is Reduced in Borderline 
Personality Disorder, but not in Posttraumatic Stress Disorder and Bulimia 
Nervosa. World Journal of Biological Psychiatry:1-8. 
 
Schnurr PP, Lunney CA, Sengupta A, 2004. Risk Factors for the Development 
Versus Maintenance of Posttraumatic Stress Disorder. Journal of 
Traumatic Stress 17:85-95. 
 
Scott KM, McGee MA, Wells JE, 2008. Obesity and Mental Disorders in the Adult 
General Population. Journal of Psychosomatic Research 64:97-105. 
 
Sessle BJ, 1990. Central Nervous System Mechanisms of Muscular Pain. 
Advances in Pain Research and Therapy 17:87-105. 
 
Sharp TJ, Harvey AG, 2001. Chronic Pain and Posttraumatic Stress Disorder: 
Mutual Maintenance? Clinical Psychology Review 21:857-877. 
  54 
Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, 2007. 
Veterans Seeking Treatment for Posttraumatic Stress Disorder: What 
About Comorbid Chronic Pain. Journal of Rehabilitation Research & 
Development 44:153-166. 
 
Solter V, Thaller V, Karlovic D, 2002. Elevated Serum Lipids in Veterans with 
Combat-Related Chronic Posttraumatic Stress Disorder. Croatian Medical 
Journal 43:685-689. 
 
Sorenson J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M, 
1997. Fibromyalgia - Are There Different Mechanisms in the Processing of 
Pain? A Double Blind Crossover Comparison of Analgesic Drugs. Journal 
of Rheumatology 24:1615-1621. 
 
Spielberger CD, 1989. State-Trait Anciety Inventory: Bibliography (2nd ed). Palo 
Alto, CA: Consulting Psychologists Press. 
 
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA, 1983. Manual 
for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting 
Psychologists Press. 
 
Turk DC, 2002. A Diathesis-Stress Model of Chronic Pain and Disability 
Following Traumatic Injury. Pain Research & Management 7:9-19. 
 
Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM, 1998. Prevalence of 
Chronic Benign Pain Disorder Among Adults: a Review of the Literature. 
Pain 77:231-239. 
 
Violanti JM, Fekedulegn D, Hartley TA, 2006. Police Trauma and Cardiovascular 
Disease: Association Between PTSD Symptoms and Metabolic Syndrome. 
The International Journal of Emergency Mental Health 8:227-237. 
 
Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE, 2005. Regression 
Methods in Biostatistics.  (Gail M, ed). New York, NY: Springer; 126. 
 
Walker EA, Katon W, Russo J, Ciechanowski P, Newman E, Wagner AW, 2003. 
Health Care Costs Associated with Posttraumatic Stress Disorder 
Symptoms in Women. Archives of General Psychiatry 60:369-374. 
 
Wall PW, 1978. On the Relation of Injury to Pain. Pain 6:253-264. 
 
Weisberg JN, Vaillancourt PD, 1999. Personality Factors and Disorders in 
Chronic Pain. Seminars in Clinical Neuropsychiatry 4:155-166. 
 
  55 
White P, Fuastman W, 1989. Coexisting Physical Conditions Among Inpatients 
with Post-Traumatic Stress Disorder. Military Medicine 154:66-71. 
  
VITA 
 
          
 
 
 
 
               
 
    
 
                  
          
  
 
             
 
  
                                                                                
 
 
                                                                      
